A novel prognostic framework for HBV-infected hepatocellular carcinoma: insights from ferroptosis and iron metabolism proteomics
Briefings in Bioinformatics · 2025
DOI: 10.1093/bib/bbaf216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2025. Verfasst von Zhiwei Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, 800 Dongchuan Road, Minhang…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Ferroptosis, Iron. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, Neil Shen's SJTU Medical Research Fund, Science and Technology Innovation Key R&D Program of Chongqing.
Abstract (Originalsprache)
Effective classification methods and prognostic models enable more accurate classification and treatment of hepatocellular carcinoma (HCC) patients. However, the weak correlation between RNA and protein data has limited the clinical utility of previous RNA-based prognostic models for HCC. In this work, we constructed a novel prognostic framework for HCC patients using seven differentially expressed proteins associated with ferroptosis and iron metabolism. Furthermore, this prognostic model robustly classifies HCC patients into three clinically relevant risk groups. Significant differences in overall survival, age, tumor differentiation, microvascular invasion, distant metastasis, and alpha-fetoprotein levels were observed among the risk groups. Based on the prognostic model and known biological pathways, we explored the potential mechanisms underlying the inconsistent differential expression patterns of FTH1 (Ferritin heavy chain 1) mRNA and protein. Our findings demonstrated that tumor tissues in HCC patients promote liver cancer progression by downregulating FTH1 protein expression, rather than upregulating FTH1 mRNA expression, ultimately leading to poor prognosis. Subsequently, based on risk score and tumor size, we developed a nomogram for predicting the prognosis of HCC patients, which demonstrated superior predictive performance in both the training and validation cohorts (C-index: 0.774; AUC for 1–5 years: 0.783–0.964). Additionally, our findings demonstrated that the adverse prognosis of high-risk HCC patients was closely correlated with ferroptosis in liver cancer tissues, alterations in iron metabolism, and changes in the tumor immune microenvironment. In conclusion, our prognostic model and predictive nomogram offer novel insights and tools for the effective classification of HCC patients, potentially enhancing clinical decision-making and outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, 800 Dongchuan Road, Minhang District, Shanghai 200240, China.
- Department of Orthopedic Oncology, Shanghai Bone Tumor Institute, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Hongkou District, Shanghai 200080, China.
- SJTU-Yale Joint Center of Biostatistics and Data Science, National Center for Translational Medicine, Shanghai Jiao Tong University, 800 Dongchuan Road, Minhang District, Shanghai 200240, China.
- Institute of Bioinformatics, Shanghai Academy of Experimental Medicine, 528 Hongshan Road, Pudong New District, Shanghai 200126, China.
- Department of Biostatistics, Yale University, 300 George Street, New Haven, CT 06511, United States.
- Shanghai Engineering Research Center for Big Data in Pediatric Precision Medicine, Center for Biomedical Informatics, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, 1400 Beijing West Ro…
Förderung
- Science and Technology Commission of Shanghai Municipality
- Neil Shen's SJTU Medical Research Fund
- Science and Technology Innovation Key R&D Program of Chongqing
- Computational Biology Program of Science and Technology Commission of Shanghai Municipality
- Neil Shen’s SJTU Medical Research Fund
Zitieren
APA
Cheng, Z., Ren, Y., Wang, X., Zhang, Y., Hua, Y., Zhao, H., & Lu, H. (2025). A novel prognostic framework for HBV-infected hepatocellular carcinoma: insights from ferroptosis and iron metabolism proteomics. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf216
Vancouver
Cheng Z, Ren Y, Wang X, Zhang Y, Hua Y, Zhao H, et al. A novel prognostic framework for HBV-infected hepatocellular carcinoma: insights from ferroptosis and iron metabolism proteomics. Briefings in Bioinformatics. 2025. doi:10.1093/bib/bbaf216
BibTeX
@article{Cheng2025,
author = {Cheng, Zhiwei and Ren, Yongyong and Wang, Xinbo and Zhang, Yuening and Hua, Yingqi and Zhao, Hongyu and Lu, Hui},
title = {A novel prognostic framework for HBV-infected hepatocellular carcinoma: insights from ferroptosis and iron metabolism proteomics},
journal = {Briefings in Bioinformatics},
year = {2025},
doi = {10.1093/bib/bbaf216}
}
EUVIMED